New Levofloxacin Product Approved by FDA

Published Online: Tuesday, June 5th, 2018
Officials with the FDA have approved Lannett Company’s Abbreviated New Drug Application (ANDA) for Levofloxacin Oral Solution USP, 25 mg/mL, the therapeutic equivalent to the reference listed drug, Levaquin Oral Solution, 25 mg/mL, of Janssen Pharmaceuticals, Inc.1

Levofloxacin is a fluoroquinolone antibiotic medicine used in adults aged 18 years and older to treat certain bacterial infections, including some types of pneumonia and bronchitis. Chronic prostate infection, urinary tract infection, uncomplicated acute kidey infection, sinus infection and skin infections also can be treated with levofloxacin. In addition, the drug is used to treat inhalation anthrax and plague.2

"Our ANDA for Levofloxacin Oral Solution, a paragraph IV product, was approved 3 weeks ahead of the Target Action Date," said Tim Crew, CEO of Lannett, in a  prepared statement.1 "While the commercial opportunity for our levofloxacin product is modest, the expected near-term launch is further evidence of our growing operational effectiveness. We continue to make progress unlocking the value of our many approved products pending launch and expect to announce additional product launches in the coming months."

References
  1. Lannett Receives FDA Approval For Levofloxacin Oral Solution; Imminent Launch Anticipated [news release]. Philadelphia, PA: June 1, 2018; Cision PR Newswire website. https://www.prnewswire.com/news-releases/lannett-receives-fda-approval-for-levofloxacin-oral-solution-imminent-launch-anticipated-300657975.html#. Accessed June 5, 2018.
  2. US Food and Drug Administration. Medication guide: Levaquin (levofloxacin ). FDA website. Lhttps://www.fda.gov/downloads/Drugs/DrugSafety/ucm088619.pdf. Accessed June 5, 2018.


Current Issue

The Educated Patient

Kristen Marjama, DNP, APRN-BC
Although the rate of foot and leg amputation has greatly declined over the past 2 decades, increasing awareness for macrovascular and microvascular complications of diabetes is essential because diabetes is the leading cause of lower-limb amputations in the United States.
Kristen Marjama, DNP, FNP-BC
Gluten proteins found in barley, rye, and wheat trigger systemic injury primarily to the small intestine, but they can also affect the joints, liver, skin, uterus, and other organs.
Kristen Marjama, DNP, FNP-BC
It is that time of year again, when health care providers see an increase in patient volume because no one has time to be sick.
Sara Marlow, MSN, RN, PHN, FNP-C
Sunburn is still a major health issue that can be prevented.
$vacMongoViewPlus$ $vAR$
Contemporary Clinic
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
ONCLive
OTCGuide
Pharmacy Times
Specialty Pharmacy Times
Targeted Oncology
About Us
Advertise
Careers
Contact Us
Feedback
Privacy
Terms & Conditions
Pharmacy Healthcare & Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-257-0701

Copyright Contemporary Clinic 2018
Pharmacy Healthcare & Communications, LLC. All Rights Reserved.